Effect of Hepatic and Renal Impairment on the Pharmacokinetics, Safety and Tolerability of BAY1841788 (ODM-201)

Clinical trial NCT02894385 · COMPLETED

Trial details

NCT number: NCT02894385
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Pharmacokinetics Hepatic Insufficiency Renal Insufficiency

Start date: 2016-09-13
Primary completion: 2017-04-10
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.